Skip to main content
logo
Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
145.43
+1.50 (1.04%)
Sep 14, 2026, 1:28 PM EDT - Market open

Merck & Co. Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
66,56965,76865,01164,23563,61663,92264,16863,17462,48061,40360,11559,31558,31157,86959,28358,97457,16953,97848,70446,131
Revenue Growth
4.64%2.89%1.31%1.68%1.82%4.10%6.74%6.51%7.15%6.11%1.40%0.58%2.00%7.21%21.72%27.84%30.21%28.96%17.31%8.70%
Gross Profit
50,52650,46150,19650,00849,24649,26549,47048,38847,35245,96144,20043,35242,69842,10042,07741,52440,19838,12735,23833,620
Operating Income
23,48324,53324,46727,18923,84824,41124,88916,13818,63717,53015,97420,95719,88319,81620,49019,76119,48218,12313,89313,635
Net Income
3,1738,93518,25419,03416,40617,43417,11712,14813,7362,3063654,6083,11113,03014,51915,26016,57914,18013,0497,197
Earnings Per Share
1.273.587.287.566.496.886.744.785.390.900.141.801.235.125.716.016.535.595.142.84
EPS Growth
-80.37%-48.02%8.01%58.24%20.41%667.14%4714.29%165.47%339.23%-82.49%-97.55%-70.02%-81.21%-8.35%11.15%111.76%196.52%101.79%84.61%-37.32%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Keytruda/Keytruda Qlex
32,91932,50931,68031,14430,42629,74029,48228,25427,16326,16425,01223,85422,94221,92320,93720,06419,17218,09617,18616,602
Gardasil/Gardasil 9
5,0184,9755,2335,7526,3097,6618,5838,9049,1839,1638,8868,4858,1947,4106,8986,9566,6556,2155,6725,142
Januvia/Janumet
2,1282,3222,5442,5302,3882,3942,2682,5682,9213,1563,3663,4923,7904,1594,5124,9925,1985,2265,2885,223
ProQuad/M-M-R II/Varivax
2,4332,4502,4512,4262,4452,4532,4842,4352,4452,4102,3682,3492,3042,3002,2422,2252,2182,1562,1352,114
Bridion
1,9071,8711,8401,7901,7711,7651,7641,7441,7481,7951,8421,8541,8531,7771,6851,6801,6261,5871,5321,451
Lynparza - Alliance
1,4741,4791,4501,4261,3841,3311,3111,2611,2231,2161,1991,1761,1611,1261,1171,0931,0551,028990928
Winrevair
1,9401,6881,4431,176965699--------------
Lenvima - Alliance
1,0691,0511,0531,0361,0291,0131,010981990983960950892881876866852802705657
Animal Health
6,6866,5576,3546,2466,1185,9545,8775,7585,6715,6455,6255,5775,5485,5595,5505,5815,6275,6325,5685,475
Other Product
3203585156488259378929189908909071,1161,4421,6901,7271,5281,144724383129
Revenue (Total)
66,56965,76865,01164,23563,61663,92264,16863,17462,47961,40260,11559,31458,31157,86959,28358,97457,16953,97848,70446,131

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
7,1415,70214,56518,2148,6229,22813,68914,59311,3545,6197,0938,7736,37810,38713,19211,24810,1298,9328,09610,042
Total Debt
53,91149,11750,53441,37435,40234,84438,27038,13137,78834,21936,26834,86736,91130,74731,98530,41831,66331,79434,63126,441
Net Cash (Debt)
-46,770-43,415-35,969-23,160-26,780-25,616-24,581-23,538-26,434-28,600-29,175-26,094-30,533-20,360-18,793-19,170-21,534-22,862-26,535-16,399
Net Cash Growth
--------------------
Net Cash Per Share
-18.85-17.42-14.35-9.19-10.58-10.09-9.67-9.26-10.37-11.24-11.45-10.24-12.01-8.00-7.39-7.55-8.49-9.01-10.46-6.46

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
19,96717,89016,47217,06518,53420,87821,46818,26416,69014,75713,00617,19015,07515,67319,09519,69618,89117,22014,10913,072
Capital Expenditures
-3,904-3,775-4,112-4,016-3,812-3,839-3,372-3,424-3,543-3,717-3,863-4,023-4,247-4,411-4,388-4,447-4,493-4,350-4,448-4,671
Free Cash Flow
16,06314,11512,36013,04914,72217,03918,09614,84013,14711,0409,14313,16710,82811,26214,70715,24914,39812,8709,6618,401
Free Cash Flow Growth
9.11%-17.16%-31.70%-12.07%11.98%54.34%97.92%12.71%21.42%-1.97%-37.83%-13.65%-24.80%-12.49%52.23%81.51%107.08%93.27%66.22%21.65%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
75.90%76.73%77.21%77.85%77.41%77.07%77.09%76.59%75.79%74.85%73.53%73.09%73.22%72.75%70.98%70.41%70.31%70.63%72.35%72.88%
Operating Margin
35.28%37.30%37.64%42.33%37.49%38.19%38.79%25.55%29.83%28.55%26.57%35.33%34.10%34.24%34.56%33.51%34.08%33.58%28.52%29.56%
Pretax Margin
8.94%17.68%32.41%33.96%30.12%31.55%31.07%21.72%24.41%6.37%3.14%12.56%9.28%26.32%27.74%28.55%32.40%29.18%28.50%16.10%
Profit Margin
4.77%13.59%28.08%29.63%25.79%27.27%26.67%19.23%21.98%3.76%0.61%7.77%5.33%22.52%24.49%25.88%29.00%26.27%26.79%15.60%
FCF Margin
24.13%21.46%19.01%20.31%23.14%26.66%28.20%23.49%21.04%17.98%15.21%22.20%18.57%19.46%24.81%25.86%25.19%23.84%19.84%18.21%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
3.3203.2803.2403.2003.1603.1203.0803.0403.0002.9602.9202.8802.8402.8002.7602.7202.6802.6402.6002.560
Dividend Per Share Growth
5.06%5.13%5.20%5.26%5.33%5.41%5.48%5.56%5.63%5.71%5.80%5.88%5.97%6.06%6.15%6.25%6.35%6.45%6.56%7.56%
Dividend Yield
2.58%2.75%3.12%3.90%4.13%3.63%3.26%2.84%2.59%2.41%2.90%3.05%2.70%2.91%2.77%3.54%3.32%3.66%3.89%3.95%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
100.0233.2814.3111.0112.1213.0114.7023.7022.83144.92756.8856.6994.1220.7319.3814.3013.9114.6314.8426.42
Forward PE
20.9223.4712.189.168.8310.0011.0513.3113.9715.3517.4713.3315.7115.2415.4512.5113.1511.2310.9712.56
P/FCF Ratio
19.7621.0721.1416.0713.5013.3113.9119.4023.8530.2730.2219.8427.0423.9819.1314.3116.0116.1120.0422.63
PS Ratio
4.774.524.023.263.133.553.924.565.025.444.604.405.024.674.753.704.033.843.984.12